Clinical Trial: A Phase 1 Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06983743) titled 'A Phase 1 Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors' on May 14.

Brief Summary: The main purpose of the study is to assess whether the study drug, ERAS-0015, is safe and tolerable when administered to patients with advanced or metastatic solid tumors with certain RAS mutations. ERAS-0015 will be given alone or in combination with other treatments.

Study Start Date: May 19

Study Type: INTERVENTIONAL

Condition: Metastatic Solid Tumors

Intervention: DRUG: ERAS-0015

ERAS-0015 Administered orally

DRUG: ERAS-0015 in combination

ERAS-0015 Administered orally and in combination with either Keytruda (pemb...